Clinical Trial Update: 68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating PET imaging with 68Ga-Dotatate and MRI-guided radiation dose escalation for high-risk or recurrent meningioma has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Snippet

Sponsor: Thomas Jefferson University | Conditions: High Risk Meningioma, Recurrent Meningioma | Phase 1 | Status: SUSPENDED